Another Good Day for Biotech Stocks:Incyte(INCY), Martek(MATK) and XBI
Clinical News and M&A Boost Biotechs Biotech stocks continued their seasonal strength with many winners in the mid-cap sector. Our index of 33 mid-cap stocks was up 2.7% which is unusually strong. Leaders were Incyte (INCY), Martek Biosciences (MATK) and the ETF XBI which owns a position in...
Weekly News Update: Dx Patents, XMRV, Avastin, Healthcare Reform
Significant Life Science News This Week Diagnostic Tests Can Be Patented, U.S. Court Rules – Bloomberg New Blood-Screening Advised – WSJ.com WABE: FDA Rules On Avastin Breast Cancer Drug (2010-12-17) Long legal fight ahead for health law – Politics – More politics...
Biotech Rally Rolls On-Intermune (ITMN) Up 130%
Biotech Outperforms Large Cap Pharma Biotechnology stocks were up today sparked by Intermune (ITMN $32.74)news that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending their Esbriet (pirfenidone) drug for...
Healthcare Stocks Come in Many Flavors: Biotech, Drugs, Life Sciences, MedTech
Investors in healthcare should look deeper into subsectors: biotechnology, devices, diagnostics, drugs and tools As of December 15 the S&P was up 12.94% but the healthcare sector was the laggard up only 0.43%. Compare this to the leaders Consumer Discretionary up 24.34%, Industrials up...
Rayno Life Science Portfolio:Dx and Tools Update 12/15/10
2010 Original Price % Ret. P Price % Recomm 3/29/10 Q2 12/1/10 Ret. Abaxis ABAX 2/2/09 15 79 21.2 27.86 85 CardioV.Sys. CSII 11/5/10 7.15 8.65 21 Celera CRA 3/28/10 7 6.49 5.66 -19 Exact Sci EXAS 12/10/10 5.6 GenProbe GPRO 2/2/09 45 7 46.3 52.77 17 Illumina ILMN 2/2/09 29 35 43.1 61.79 113...
